Curative Technologies Inc. (NASDAQ:CURE) of East Setauket,N.Y., has been awarded U.S. patent No. 5,165,938 coveringwound healing agents derived from platelets. The patent coversboth the autologous platelet releasate Procuren--which is onthe market--and the homologous releasate CT102.

(c) 1997 American Health Consultants. All rights reserved.

No Comments